- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- PL Intelligence
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- PL Intelligence
- Overview
- Industry news
- Deals review
- Press releases
- Articles
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
is a division of
- Deals review
- Deal details
Regeneron initiates phase II obesity clinical trial
In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Related deals
Emisphere Technologies establishes obesity collaboration with Regeneron
Regeneron And Aventis Begin Study Of Intravenous VEGF Trap In Cancer
Valentis initiates gene therapy clinical trial
Periodontix initiates Phase I/II mouthwash clinical
StressGen Initiates Phase II clinical trial of HspE7
Carrington initiates phase III ulcerative colitis trial
SANGART INITIATES PHASE II CLINICAL TRIAL FOR HEMOSPAN™ AND ANNOUNCES NEW GRANT FUNDING
Cellectis and Regeneron sign an agreement over the use of homologous recombination technology
Artemis Pharmaceuticals and Regeneron Pharmaceuticals sign Licensing Agreement
Related categories
- Therapeutic target
- Metabolism
- Industry sector
- Pharmaceutical
More deals
Latest deals
- Antitope Ltd and Vascular Pharmaceuticals Enter into a Antibody Research Agreement
- Bayer Schering Pharma Extends Research Portfolio in the Field of Cancer-Related Targets
- Bayer CropScience and Monsanto sign cross licensing agreement on herbicide tolerance traits in rapeseed/canola
- GVK Biosciences announces Agreement With University of Tokyo on GPCR Database
- Wockhardt signs agreement to divest its Animal Health Division
Most viewed deals
- Bayer CropScience and Janssen PMP conclude research agreement:
- Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded to Singapore and Vietnam
- Bayer CropScience and Evogene to extend collaboration for rice yield improvement
- Galapagos and Opsona Therapeutics initiate drug discovery collaboration
- Merck & Co., Inc., Medarex, Inc. and Massachusetts Biologic Laboratories Sign Exclusive Licensing Agreement for Investigational Monoclonal Antibody Combination for Clostridium Difficile Infection
© Copyright 1995-2009 Pharmalicensing, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us